Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018

IMPORTANCE: Government efforts to lower drug costs and other legislative and regulatory initiatives may be counteracted by campaign donors and lobbyists in the pharmaceutical and health product industry. OBJECTIVE: To review how much money the pharmaceutical and health product industry spent on camp...

Descripción completa

Detalles Bibliográficos
Autor principal: Wouters, Olivier J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054854/
https://www.ncbi.nlm.nih.gov/pubmed/32125357
http://dx.doi.org/10.1001/jamainternmed.2020.0146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054854/
https://www.ncbi.nlm.nih.gov/pubmed/32125357
http://dx.doi.org/10.1001/jamainternmed.2020.0146

Ejemplares similares